Frailty and the somatopause

Growth Hormone and IGF Research

Volumn 9, Issue 1, 1999, Pages 3-10

  Martin, F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; IBUTAMOREN; PRALMORELIN; SEX HORMONE; SOMATOMEDIN C;

AGING; BONE MASS; CARPAL TUNNEL SYNDROME; DEMENTIA; DISABILITY; EXERCISE; GROWTH HORMONE RELEASE; GYNECOMASTIA; HORMONAL THERAPY; HYPERGLYCEMIA; LIFE EXPECTANCY; MUSCLE ATROPHY; OSTEOPOROSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

EID: 0033081429     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Rudman D. Growth hormone, body composition and ageing. J Am Geriatr Soc 1985; 33: 800-807.
2. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1-6.
3. Hodes RJ. Frailty and disability: Can growth hormone or other trophic agents make a difference? J Amer Geriatr Soc 1994; 42: 1208-1211.
4. Marcus R, Hoffman AR. Growth hormone therapy for older men and women (review). Ann Rev Pharmacol Therapeutics 1998: 38: 45-61.
5. Butler RN. Population aging and health. Br Med J 1997; 315: 1082-1084.
6. Khaw K-T. Healthy aging. Br Med J 1997; 315: 1090-1096.
7. Boyce WJ, Vessey MP. Rising incidence of fracture of the proximal femur. Lancet 1985; I:150-151.
8. Fries JF. Aging, natural death and the compression of morbidity. New Engl J Med 1980; 313: 407-428.
9. Manton KG, Corder L, Stallard E. Chronic disability trends in elderly United States populations: 1982-1994. Proc Natl Acad Sci USA 1997; 25: 93-98.
10. Fries JF. Physical activity, the compression of morbidity and the health of the elderly. J R Soc Med 1996; 89: 64-68.
11. World Health Organisation. International Classification of Impairments, Disabilities and Handicaps: A Manual of Classification Relating to the Consequences of Disease. Geneva: WHO, 1980.
12. Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age Ageing 1997; 26: 315-318.
13. Rowe JW, Kahn RL. Human aging: Usual and successful. Science 1987; 237: 143-149.
14. Roubenhoff R, Harris TB. Failure to thrive, sarcopenia and functional decline in the elderly. Clin Geriatric Med 1997; 13: 613-622.
15. Young A. Muscle function in old age. New Issues Neurosci 1988; 1: 141-156, 235-266.
16. Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing 1994; 23: 371-377.
17. Guralnik JM, Branch LG, Ferrucci L, et al. A Short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49: M106-M110.
18. Laukkanen P, Heikkinen E, Kauppinen N. Muscle strength and mobility as predictors of survival in 75-84 year old people. Age Ageing 1995; 24: 468-473.
19. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769-1775.
20. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-1803.
21. Cranston I, Marsden PK, Carroll P, et al. Effects of hgh replacement on cerebral metabolism in adults with growth hormone deficiency. Growth Hormone and IGF Research 1998; 8: 317.
22. McGauley GA, Cuneo RC, Salomon F, et al. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res 1990; 33(Suppl. 4): 52-54.
23. Aleman A, Verhaar HJJ, de Haan EHF, et al. Growth hormone and cognitive function in healthy older men. Growth Hormone IGF Res 1998; 8: 329.
24. Rudman D, Kutner MH, Rogers CM, et al. Impaired growth hormone secretion in the adult population J Clin Invest 1981; 67: 1361-1369.
25. Zadik Z, Calew SA, McCarter RJ, et al. The influence of age on the 24-hour integrated growth hormone concentration in normal individuals. J Clin Endocrinol Metab 1985; 60: 513-516.
26. Corpas E, Harman SM, Pineyro MA, et al. Growth hormone (gh)-releasing hormone (1-29) twice daily reverses the decreased GH and insulin-like growth factor-1 levels in old men. J Clin Endocrinol Metab 1992; 75: 530-535.
27. Corpas E, Harman SM & Blackman MR. Human growth hormone and human aging. Endocrine Reviews 1993; 14: 20-39.
28. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative obesity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991; 73: 1081-1088.
29. Toogood AA, O'Neill PA, Shalet SM. Beyond the somatopause: Growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab 1996; 82: 460-465.
30. Florini JR, Prinz PN, Vitiello MB, Hintz RL. Somatomedin C levels in healthy young and old men: Relationship to peak and 24 hour integrated levels of growth hormone. J Gerontology 1985; 40: 2-7.
31. Vermeulen A. Nyctohemeral growth hormone profiles in young and aged men: Correlation with somatomedin-c levels. J Clin Endocrinol Metab 1987; 64: 884-888.
32. Juul A, Main K, Blum WF, et al. The ratio between insulin-like growth factor-i (IGF-I) and the igf-binding proteins (IGFBP-1,2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol 1994; 41: 85-93.
33. Erfurth EM, Hagmar L. Serum IGF-I and IGFBP-3 levels and their relation to body composition in a cross-sectional study of 100 80 years old subjects. Endocrinology Metabolism 1997; 4 (Suppl. A): P-125.
34. Rudman D, Mattson De. Serum insulin-like growth factor-i in healthy older men in relation to physical activity. J Am Geriatr Soc 1994; 42: 71-76.
35. Hong Y, Pedersen NL, Brismar K, et al. Quantitative genetic analyses of insulin like growth factor-i (IGF-I), igf-binding protein-i, and insulin levels in middle aged and elderly twins. J Clin Endocrinol Metab 1996; 81: 1791-1797.
36. Rudman D, Shetty KR. Unanswered questions concerning the treatment of hyposomatotropism and hypogonadism in elderly men. J Am Geriatr Soc 1994; 42: 522-527.
37. Rudman D, Kutner MH, Rogers CM, et al. Impaired growth hormone secretion in the adult population. J Clin Invest 1981; 67: 1361-1369.
38. Harris TB, Kiel D, Roubenoff R, et al. Association of insulin-like growth factor I with body composition, weight history and past health behaviors in the very old: The Framingham heart study. J Am Geriatr Soc 1997; 45: 133-139.
39. Urban RJ. Neuroendocrinology of ageing in the male and female. Endocrinol Metab Clin N Am 1992; 21: 817-832.
40. Kelijman M. Age related alterations of the growth hormone/insulin-like growth factor I axis. J Am Geriatr Soc 1991; 39: 295-307.
41. Ghigo E, Arvat E, Goffi S, et al. Neural control of growth hormone secretion in aged humans. In Muller EE, Cocchi D, Locatelli V (eds). Growth Hormone and Somatomedins During Lifespan. Berlin, Heidelberg: Springer-Verlag, 1993; pp. 276-287.
42. Veldhuis JD, Liem AY, South S, et al. Differential impact of age, sex steroid hotmones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescent assay. J Clin Endocrinol Metab 1995; 80: 3209-3222.
43. O'Neil PA. Aging homeostasis. Rev Clin Gerontology 1997; 7: 199-211.
44. Balodpal P, Rooyackers OE, Adey DB, Nair KS. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy chain and sacroplasmic protein in humans. Am J Physiol 1997; 273: E790-E800.
45. Goodman-Gruen-D, Barrett-Connor-E. Epidemiology of insulin-like growth factor-i in elderly men and women. The Rancho Bernardo study. Am J Epidemiol 1997; 145: 970-976.
46. Benbassat-CA, Maki-KC, Unterman-TG. TI: Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: Relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 1997; 82: 1484-1491.
47. Boonen S, Lesaffre E, Aerssens J, et al. deficiency of the growth hormone-insulin-like growth factor-i axis potentially involved in age-related alterations in body composition. Gerontology 1996; 44: 1301-1306.
48. Porch JV, Jain K, Reilly A, Valdez C, et al. Aging, physical activity, insulin-like growth factor I, and body composition in Guatemalan women. Am J Clin Nutr 1997; 66: 874-879.
49. Sturgess I, Martin FC. Correlation of techniques of body composition estimation with muscle strength and insulin like growth factor-1 in fit elderly subjects. XVth World Congress of Gerontology, 1993.
50. Papadakis MA, Grady D, Tierney M. Insulin-like growth factor-i and functional status in healthy old men. J Am Geriatr Soc 1995; 43: 1350-1355.
51. Paolisso G, Ammendola S, Del-Buono A, et al. Serum levels of insulin-like growth factor-i (IGF-I) and igf-binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 1997; 82: 2204-2209.
52. Boonen S, Lesaffre E, Dequeker J, et al. Relationship between baseline insulin-like growth factor-i (IGF-I) and femoral bone density in women aged over 70 years: Potential implications for the prevention of age-related bone loss. J Am Geriatr Soc 1996; 44: 1301-1306.
53. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K. Serum levels of insulin-like growth factor (IGF) I, igf-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 1997; 12: 1272-1279.
54. Toogood AA, Adams JE, O'Neill PA, Shalet SM. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 1997; 82: 1462-1466.
55. Kurland E, Rosen CJ, Cosman F, et al. Insulin-like growth factor-i in men with idiopathic osteoporosis. J Clin Endocrinol Metab, 1997; 82: 2799-2805.
56. Vermeulen A, Kaufman JM, Giagulli JA. Influence of some biological indices on sex-hormine binding globulin and androgen levels in aging an obese males. J Clin Endocrinol Metab 1996; 81: 1821-1826.
57. Shetty KR, Sutton CH, Mattson DE, Rudman D. Hyposomatomedinemia in quadriplegic men. Am J Med Sci 1993; 305: 95-100.
58. Poehlman EH, Copeland KC. Influence of physical activity on insulin-like growth factor-i in healthy younger and older men. J Clin Endocrinol Metab 1990; 71: 1468-1473.
59. Hagberg JM, Seals DR, Yerg JE, et al. Metabolic responses to exercise in young and old athletes and sedentary men. J Appl Physiol 1988; 65: 900-908.
60. Horber FF, Kohler SA, Lippuner K, Jaeger P. Effect of regular physical training on age associated alteration of body composition in men. Eur J Clin Invest 1996; 26: 279-285.
61. Weltman A, Weltman JR, Schurrer R, et al. Endurance training amplifies the pulsatile release of growth hormone: Effects of training intensity. J Appl Physiol 1992; 72: 2188-2196.
62. Borst SE, Millard WJ, Lowenthal DT. Growth hormone, exercise and ageing: The future of therapy for the frail elderly. J Am Geriatr Soc 1994; 42: 528-535.
63. Hartman ML, Clasey JL, Weltman JY, et al. Fitness is related to 24 hr GH release in older men but not women. Endocrinol Metab 1997; 4 (Suppl. A): P-140.
64. Pyka G Wiswell RA, Marcus R. Age-dependent effect of resistance exercise on growth hormone secretion in people? J Clin Endocrinol Metab 1992; 75: 404-407.
65. Nicklas BJ, Ryan AY, Treuth MM, et al. Testosterone, growth hormone and IGF-I responses to acute and vhronic resistive exercises in men aged 55-70 years. Int J Sports Med 1995; 16: 445-450.
66. Vitiello MV, Wilkinson CW, Merriam GR, et al. Successful six months endurance training does not alter insulin-like growth factor-i in healthy older men and women. J Gerontology 1997; 52: M149-154.
67. Poehlman EH, Rosen CJ, Copeland KG. The influence of endurance training on insulin-like growth factor-i in older individuals. Metabolism 1994; 43: 1401-1405.
68. Taaffe DR, Pruitt L, Reim J, et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994; 79: 1361-1366.
69. Zachwieja JJ, Toffolo G, Cobelli C, et al. Resistance exercise and growth hormone administration in older men: Effects on insulin sensitivity and secretion during a stable-label intravenous glucose tolerance test. Metabolism 1996; 45: 254-260.
70. Cuneo RC, Salomon F, Wiles CM, et al. Growth hormone treatment in growth hormone-deficient adults. J Appl Physiol 1991; 70: 688-700.
71. Devol DL, Rotwein P, Sadow JL, Novakofski PJ, Bechtel PJ. Activation of insulin-like growth factor gene expression during work induced skeletal muscle growth. Am J Physiol 1990; 259: E89-E95.
72. Johanson AJ, Blizzard RM. Low somatomedin C levels in older men rise in response to growth hormone administration. John Hopkins Med J 1981; 149: 115-117.
73. Marcus R, Butterfield G, HoLLoway L, et al. Effects of short term administration of recombinant growth hormone to elderly people. J Clin Endocrinol Metab 1990; 70: 519-527.
74. Cohn L, Feller AG, Draper MW, et al. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol 1993; 39: 417-425.
75. Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Int Med 1996; 124: 708-716.
76. Bonello RS, Marcus R, Bloch D, Strober S. Effect of growth hormone and estrogen on T lymphocytes in older women. J Am Geriatr Soc 1996; 44: 1038-1042.
77. Thompson JL, Butterfield GE, Marcus R, et al. The effects of recombinant human insulin-like growth factor I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 1995; 80: 1845-1849.
78. Corpas E, Harman SM, Pineyro MA, et al. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-i levels in old men. J Clin Endocrinol Metab 1993; 76: 134-138.
79. Kaiser FE, Silver AJ, Morley JE. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc 1991; 39: 235-240.
80. Ahlmen J, Johannsson G, Johannsson J, Bengtsson B-A. Beneficial effects of GH treatment in elderly patients on dialysis Endocrinol Metab 1997; 4 (Suppl. A) 18.
81. Weissburger AJ, Anastasiadis AD, Sturgess I, et al. Recombinant human growth hormone (GH) treatment in elderly patients undergoing total hip replacement: Effects on muscle mass and strength. Endocrinol Metab 1997; 4 (Suppl. A): 19.
82. Yeo A, Levy D, Martin FC, et al. Physical frailty and the response to growth hormone in elderly women with hip fracture. Age Ageing 1996; 25(Suppl. 2): P6.
83. Martin FC, Levy D, Sonksen P, et al. Frailty and response to growth hormone after hip fracture. Endocrinol Metab 1997; 4 (Suppl. A): 19.
84. Chapman IR, Bach MA, Cauter EV, et al. Stimulation of the growth hormone (gh)-insulin-like growth factor axis by daily oral administration of a GH secretagogue (MK677) in healthy elderly subjects. J Clin Endocrinol Metab 1996; 81: 4249-4257.